MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma

Table 1

MXRA5 immunohistochemical expression in 28 glioma tissue samples.

Samples		Expression of MXRA5		value
		Positive	Negative
LGG	15	2 (13.3%)	13 (86.6%)	0.042
GBM	13	7 (53.8%)	6 (46.2%)